Brief: Armata Pharma Qtrly Loss Per Share $0.48
19/03/2020 20:38
March 19 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL
YEAR
2019 RESULTS AND PROVIDES GENERAL CORPORATE UPDATE
* ARMATA PHARMACEUTICALS - AUDIT OPINION INCLUDED IN CO'S
FORM
10-K FOR YEAR ENDED DEC. 31, 2019 CONTAINS GOING CONCERN
EXPLANATORY PARAGRAPH
* ARMATA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.48
Source text for Eikon: ID:nPn4s37Wya
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles